(Total Views: 287)
Posted On: 10/10/2017 1:16:45 PM
Post# of 23060
$PBMD been meaning to mention this one it's an old alert that's been moving as of late. I don't see any news on it. If news hits this can move bigly. keep it on watch.
This is the latest news I have.
05:54 AM EDT, 09/08/2017 (MT Newswires) -- Prima BioMed (PBMD) said Friday that it has been granted a Japanese patent for cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease.
The company said the granted claims provide broad protection for the antibody and also use of the antibody in the manufacture of a medicament for treating or preventing organ transplant rejection or treating an autoimmune disease. The patent expires on April 30, 2028.
Price: 1.64, Change: , Percent Change:
http://www.mtnewswires.com Copyright © 2017 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
This is the latest news I have.
05:54 AM EDT, 09/08/2017 (MT Newswires) -- Prima BioMed (PBMD) said Friday that it has been granted a Japanese patent for cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease.
The company said the granted claims provide broad protection for the antibody and also use of the antibody in the manufacture of a medicament for treating or preventing organ transplant rejection or treating an autoimmune disease. The patent expires on April 30, 2028.
Price: 1.64, Change: , Percent Change:
http://www.mtnewswires.com Copyright © 2017 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
(0)
(0)
